Jeffrey Robert Ajer, Director: Nektar Therapeutics NKTR Sell · Filed 23/09/20

Trade details

Type: Insider sale
Amount: $3,007.71
Shares · price: 4,359 sh · $0.69 a share
Held after: 34,153 sh
Stock: Nektar Therapeutics NKTR
Person: Jeffrey Robert AjerDirector
Trade date: 23/09/18
Filed: 23/09/20
Days to filing: 2 days

Sold 11.3% of holdings

Share of holding sold: 11.3%

Nektar Therapeutics trades, last 26 weeks

What else happened in Nektar Therapeutics around then

Filed or reported within 30 days of the trade day · 23/08/19~23/10/18

Jeffrey Robert Ajer's recent trades

Jeffrey Robert AjerEVP, Chief Commercial Officer
Sell10b5-1 planBiomarin Pharmaceutical
Sell10b5-1 plan
Biomarin Pharmaceutical
BMRN
$414.6K
5,000 sh
$414.6K
Filed 24/05/06
Traded 24/05/02
Jeffrey Robert AjerEVP, Chief Commercial Officer
Sell10b5-1 planBiomarin Pharmaceutical
Sell10b5-1 plan
Biomarin Pharmaceutical
BMRN
$348.3K
4,000 sh
$348.3K
Filed 24/03/07
Traded 24/03/05
Jeffrey Robert AjerEVP, Chief Commercial Officer
Sell10b5-1 planBiomarin Pharmaceutical
Sell10b5-1 plan
Biomarin Pharmaceutical
BMRN
$450K
5,000 sh
$450K
Filed 23/08/17
Traded 23/08/16
Jeffrey Robert AjerEVP, Chief Commercial Officer
SellBiomarin Pharmaceutical
Sell
Biomarin Pharmaceutical
BMRN
$5.2M
44,825 sh
$5.2M
Filed 23/01/27
Traded 23/01/25
Jeffrey Robert AjerEVP, Chief Commercial Officer
SellBiomarin Pharmaceutical
Sell
Biomarin Pharmaceutical
BMRN
$484.9K
4,175 sh
$484.9K
Filed 23/01/27
Traded 23/01/25